NIFTY200 Alpha 30

Cummins India has informed that the Company is providing an update in relation to the labour dispute that was previously pending before the Industrial Court, Pune (Industrial Court) with the Kirloskar Cummins Employees' Union (Union) concerning the applicable retirement age of certain categories of workmen. Subsequent to the aforesaid disclosure, the matter underwent various stages of adjudication before the relevant authorities (the Assistant Labour Commissioner, Pune and the Industrial Court), pursuant to which the proposed modification to the certified standing orders relating to retirement age of 60 years (as against the retirement age of 58 years contended for by the Company) was upheld. The Company has challenged the relevant orders before the Hon'ble High Court of Judicature at Bombay (Bombay HC) by way of a writ petition. The Bombay HC, vide its order dated June 9, 2026, which was received by the Company on June 11, 2026, has granted interim stay on the operation and implementation of the impugned orders till next hearing date. In view of the above, the impugned orders continue to be inoperative and, accordingly, there is no material financial impact on the Company at this stage. In this regard, the legal position prevailing at the time of the Company's earlier disclosure continues to remain unchanged.

The above information is a part of company’s filings submitted to BSE.

Hitachi Energy India has informed that it enclosed a copy of the Press Release titled ‘Hitachi Energy secures India’s grid future with major manufacturing expansion’ which is being issued by the Company today to the media for information of the Stock Exchanges. This is pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Cummins India has informed that it enclosed newspaper publication regarding special window for transfer and dematerialisation of physical securities.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharmaceuticals has informed that it enclosed press release titled ‘Glenmark Launches Winlevi® (clascoterone) 10 mg/g cream in Key European Markets for the Treatment of Acne Vulgaris’.

The above information is a part of company’s filings submitted to BSE.

Aditya Birla Capital has informed that the Stakeholders Relationship Committee of the Company has approved the allotment of 60,177 Equity Shares of the face value of ₹10/- each on 10 June 2026 pursuant to exercise of Stock Options / Restricted Stock Units/ Performance Stock Units under ABCL Scheme 2022. All the said Equity Shares will rank with the existing Equity Shares of the Company, in all aspects. Consequent to the above allotment, the Paid-up Equity Share Capital of the Company will increase from ₹ 26,217,928,870 (i.e. 2,621,792,887 equity shares of face value of ₹10/- each) to ₹ 26,218,530,640 (i.e. 2,621,853,064 equity shares of face value of ₹10/- each).

The above information is a part of company’s filings submitted to BSE.